Della Porta MG - Search Results

1

Predicting survival and leukemic evolution in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Cazzola M. Malcovati L, et al. Among authors: della porta mg. Haematologica. 2006 Dec;91(12):1588-90. Haematologica. 2006. PMID: 17145593 No abstract available.

2

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: della porta mg. Br J Haematol. 2004 Sep;126(5):650-6. doi: 10.1111/j.1365-2141.2004.05098.x. Br J Haematol. 2004. PMID: 15327515 Free article.

3

Splenectomy for treatment of immune thrombocytopenic purpura.

Malcovati L, Della Porta MG. Malcovati L, et al. Among authors: della porta mg. Haematologica. 2005 Jan;90(1):4. Haematologica. 2005. PMID: 15644305 No abstract available.

4

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.

Passamonti F, Pietra D, Rumi E, Arcaini L, Della Porta MG, Malcovati L, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: della porta mg. Leukemia. 2005 May;19(5):888-9. doi: 10.1038/sj.leu.2403700. Leukemia. 2005. PMID: 15744342 No abstract available.

5

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Among authors: della porta mg. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

6

Risk factors for Gram-negative infections in neutropenic patients.

Della Porta MG, Malcovati L. Della Porta MG, et al. Haematologica. 2005 Aug;90(8):1013C. Haematologica. 2005. PMID: 16079097 No abstract available.

7

Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.

Della Porta MG, Malcovati L. Della Porta MG, et al. Haematologica. 2005 Oct;90(10):1298C. Haematologica. 2005. PMID: 16219554 No abstract available.

8

Simian virus 40 and lymphoproliferative disorder.

Della Porta MG, Malcovati L. Della Porta MG, et al. Haematologica. 2005 Dec;90(12):1587. Haematologica. 2005. PMID: 16330424 No abstract available.

9

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

Passamonti F, Rumi E, Pietra D, Della Porta MG, Boveri E, Pascutto C, Vanelli L, Arcaini L, Burcheri S, Malcovati L, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: della porta mg. Blood. 2006 May 1;107(9):3676-82. doi: 10.1182/blood-2005-09-3826. Epub 2005 Dec 22. Blood. 2006. PMID: 16373657 Free article.

10

Effects of heparins on hemostatic properties of vascular endothelium.

Della Porta MG, Malcovati L. Della Porta MG, et al. Haematologica. 2006 Feb;91(2):149a. Haematologica. 2006. PMID: 16461295 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters